Create Free Account

By creating account you will get access to hot stocks & personalised emails

XRF Scientific Ltd

Basic Materials AU XRF

1.865AUD
0.01(0.54%)

Last update at 2024-12-19T05:11:00Z

Day Range

1.811.87
LowHigh

52 Week Range

0.991.93
LowHigh

Fundamentals

  • Previous Close 1.85
  • Market Cap252.02M
  • Volume174674
  • P/E Ratio29.92
  • Dividend Yield2.15%
  • EBITDA14.46M
  • Revenue TTM60.12M
  • Revenue Per Share TTM0.44
  • Gross Profit TTM 22.98M
  • Diluted EPS TTM0.06

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax 11.79M 8.19M 6.79M 4.45M 3.15M
Minority interest -0.49522M -0.01018M - - -
Net income 7.69M 6.08M 5.13M 3.12M 2.14M
Selling general administrative 10.14M 8.53M 7.41M 7.41M 7.35M
Selling and marketing expenses - - - - -
Gross profit 22.90M 17.32M 13.79M 12.24M 11.35M
Reconciled depreciation 1.20M 1.18M 1.23M 1.25M 0.85M
Ebit 12.01M 8.26M 6.82M 4.61M 3.26M
Ebitda 13.22M 9.44M 8.05M 5.86M 4.11M
Depreciation and amortization 1.20M 1.18M 1.23M 1.25M 0.85M
Non operating income net other - - - - -
Operating income 11.97M 8.23M 5.96M 4.32M 3.26M
Other operating expenses 21.31M 13.63M 10.53M 9.20M 26.65M
Interest expense 0.22M 0.07M 0.03M 0.16M 0.11M
Tax provision 3.61M 2.10M 1.66M 1.33M 1.01M
Interest income 0.09M 0.00185M 0.00233M 0.01M 0.00730M
Net interest income -0.13548M -0.06641M -0.03040M -0.14807M -0.09854M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 3.61M 2.10M 1.66M 1.33M 1.01M
Total revenue 55.17M 40.01M 31.29M 29.08M 29.02M
Total operating expenses 12.22M 10.27M 9.06M 9.18M 8.98M
Cost of revenue 32.28M 22.69M 17.50M 16.84M 17.67M
Total other income expense net 0.04M 0.03M 0.86M 0.29M -0.10584M
Discontinued operations - - - - -
Net income from continuing ops 8.18M 6.09M 5.13M 3.12M 2.14M
Net income applicable to common shares 7.69M 6.08M 5.13M 3.12M 2.14M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 68.23M 65.55M 55.56M 48.37M 45.17M
Intangible assets 1.20M 1.35M 1.49M 1.29M 1.27M
Earning assets - - - - -
Other current assets 0.61M 0.11M 0.05M 0.03M 0.04M
Total liab 12.69M 15.97M 12.21M 9.27M 9.53M
Total stockholder equity 54.89M 49.25M 43.48M 39.10M 35.64M
Deferred long term liab - 0.86M 0.93M 0.87M 0.78M
Other current liab 5.68M 2.40M 0.89M 0.21M 0.24M
Common stock 21.41M 20.41M 19.63M 18.80M 18.58M
Capital stock 21.41M 20.41M 19.63M 18.80M 18.58M
Retained earnings 31.78M 26.65M 22.37M 18.98M 15.72M
Other liab - 1.42M 0.71M 0.60M 0.35M
Good will 15.42M 15.52M 15.46M 14.63M 14.62M
Other assets 0.00000M 1.74M 1.96M 1.92M 1.68M
Cash 12.05M 10.40M 6.65M 5.26M 3.63M
Cash and equivalents - - - - -
Total current liabilities 10.45M 11.62M 9.66M 8.44M 7.80M
Current deferred revenue 1.29M 6.88M 6.03M 6.48M 6.38M
Net debt -8.66837M -6.08726M -3.13562M -3.81541M -1.69718M
Short term debt 2.23M 1.39M 1.67M 1.21M 0.55M
Short long term debt 1.62M 0.78M 1.30M 0.82M 0.11M
Short long term debt total 3.38M 4.31M 3.51M 1.44M 1.94M
Other stockholder equity - -47.06794M -41.99732M -37.78129M -34.30637M
Property plant equipment - 10.41M 8.66M 8.75M 9.28M
Total current assets 39.20M 36.53M 28.91M 22.65M 19.11M
Long term investments - - - - -
Net tangible assets - 33.25M 27.46M 24.06M 20.53M
Short term investments - 5.00M 0.00000M 0.03M 0.03M
Net receivables 9.52M 8.63M 6.23M 4.48M 3.77M
Long term debt - 1.29M 1.46M 0.00000M 0.82M
Inventory 17.02M 16.88M 15.52M 12.52M 11.30M
Accounts payable 1.25M 0.96M 1.07M 0.54M 0.63M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 1.70M 2.19M 1.48M 1.32M 1.33M
Additional paid in capital - - - - -
Common stock total equity - - - - 18.58M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 1.20M -26.42162M -24.68412M -23.79945M -24.38215M
Deferred long term asset charges - - - - -
Non current assets total 29.03M 29.02M 26.64M 25.72M 26.06M
Capital lease obligations 1.76M 2.24M 0.75M 0.62M 1.00M
Long term debt total - 2.93M 1.84M 0.23M 1.39M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -0.78243M -1.11179M -0.65262M -0.75341M -0.64150M
Change to liabilities 0.91M 1.16M 0.39M -0.28253M 0.53M
Total cashflows from investing activities -0.78243M -1.11179M -0.65262M -0.75341M -0.64150M
Net borrowings -1.20353M 1.48M -0.58361M -1.71416M -0.01040M
Total cash from financing activities -3.88222M -0.64895M -2.23656M -3.05241M -0.41188M
Change to operating activities 0.58M -0.52637M -0.41799M 2.23M 1.12M
Net income 7.69M 6.08M 5.13M 3.12M 2.14M
Change in cash 3.75M 1.39M 1.62M 0.40M 2.82M
Begin period cash flow 6.65M 5.26M 3.63M 3.24M 0.42M
End period cash flow 10.40M 6.65M 5.26M 3.63M 3.24M
Total cash from operating activities 8.42M 3.15M 4.51M 4.20M 3.88M
Issuance of capital stock - - - - -
Depreciation 1.11M 1.07M 1.08M 1.07M 0.85M
Other cashflows from investing activities 0.00000M -0.59229M - - -0.00967M
Dividends paid 2.68M 2.13M 1.65M 1.34M 0.40M
Change to inventory -1.35778M -3.00525M -1.22033M -2.59661M -1.08602M
Change to account receivables -2.40058M -1.74995M -0.70843M 0.30M 0.05M
Sale purchase of stock - - - - -
Other cashflows from financing activities 2.20M 1.61M -0.47241M 0.43M 0.74M
Change to netincome 1.14M -0.12793M -0.00536M 0.15M 0.22M
Capital expenditures 0.78M 0.52M 0.65M 0.75M 0.64M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -3.75836M -4.75520M -1.92875M -2.29935M 0.00731M
Stock based compensation 0.33M 0.06M - - -
Other non cash items -0.37985M -3.99541M 0.23M 2.31M -2.99165M
Free cash flow 7.63M 2.63M 3.86M 3.45M -0.64150M

Peer Comparison

Sector: Basic Materials Industry: Chemicals

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
XRF
XRF Scientific Ltd		 0.01 0.54% 1.86 29.92 25.58 4.19 4.64 4.11 16.06
RDX
Redox Ltd		 0.01 0.25% 4.03 22.41 - 1.76 3.79 1.65 13.57
HZR
Hazer Group Ltd		 -0.005 1.33% 0.37 - - 27.09 6.62 - -5.1128
ANO
Advance ZincTek Limited		 - -% 0.77 - - 4.80 1.39 5.32 196.81
FGR
First Graphene Ltd		 - -% 0.03 - - 38.13 3.53 40.28 -9.7314

Reports Covered

Stock Research & News

View All

Profile

XRF Scientific Limited manufactures and markets precious metal products, specialized chemicals, and instruments for the scientific, analytical, construction material, and mining industries in Australia, Canada, and Europe. The company operates through Capital Equipment, Precious Metals, and Consumables segments. The Capital Equipment segment manufactures automated fusion equipment, high temperature test, production furnaces, and laboratory jaw crushers, as well as general laboratory equipment. The Precious Metals segment manufactures products for the laboratory and platinum alloy markets. The Consumables segment manufactures chemicals and other supplies for analytical laboratories. XRF Scientific Limited was founded in 1972 and is based in Osborne Park, Australia.

XRF Scientific Ltd

86 Guthrie Street, Osborne Park, WA, Australia, 6017

Key Executives

Name Title Year Born
Mr. Vance Stazzonelli MD, Company Sec. & Director NA
Mr. Andrew Watson B.Comm, CA CFO & Joint Company Sec. NA
Mr. Stephen Prossor Bus. Devel. Mang. NA
Mr. Gino Manfredi Gen. Mang. of XRF Labware NA
Mr. Robert McConnell Gen. Mang. of XRF Technology WA NA
Mr. Jeffrey Brown Gen. Mang. of XRF Chemicals NA
Mr. Vance Stazzonelli MD, Company Secretary & Director NA
Mr. Andrew Watson B.Comm, CA CFO & Joint Company Secretary NA
Mr. Stephen Prossor Business Development Manager NA
Mr. Vance Stazzonelli MD, Company Secretary & Director NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.